相似文献
1
Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice.
Antimicrob Agents Chemother. 1979 Apr;15(4):554-61. doi: 10.1128/AAC.15.4.554.
2
Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.
Antimicrob Agents Chemother. 1979 May;15(5):723-9. doi: 10.1128/AAC.15.5.723.
3
Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus.
J Gen Virol. 1988 Feb;69 ( Pt 2):433-8. doi: 10.1099/0022-1317-69-2-433.
4
Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
Antiviral Res. 1984 Apr;4(1-2):43-52. doi: 10.1016/0166-3542(84)90024-x.
5
Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
Arch Virol. 1981;69(1):43-8. doi: 10.1007/BF01315264.
6
Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice.
J Gen Virol. 1981 Oct;56(Pt 2):259-65. doi: 10.1099/0022-1317-56-2-259.
7
Acycloguanosine treatment of herpesvirus infections in footpads and nervous tissue of normal and immunosuppressed mice.
Intervirology. 1980;12(6):345-8. doi: 10.1159/000149095.
8
Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.
J Gen Virol. 1975 Sep;28(3):341-53. doi: 10.1099/0022-1317-28-3-341.
9
A non-lethal test of the resistance of inbred mice to herpes simplex virus type 1.
J Hyg (Lond). 1982 Oct;89(2):335-45. doi: 10.1017/s002217240007087x.
10
Latent herpes simplex virus infection of mice. Infectious virus in homogenates of latently infected dorsal root ganglia.
J Neuropathol Exp Neurol. 1978 Jan;37(1):45-55. doi: 10.1097/00005072-197801000-00004.
引用本文的文献
1
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections.
Expert Rev Anti Infect Ther. 2024 Dec;22(12):1123-1142. doi: 10.1080/14787210.2024.2420329. Epub 2024 Nov 6.
2
"Non-Essential" Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review.
Viruses. 2020 Dec 23;13(1):17. doi: 10.3390/v13010017.
3
Analysis of Herpes Simplex Virus Reactivation in Explant Reveals a Method-Dependent Difference in Measured Timing of Reactivation.
J Virol. 2017 Jul 27;91(16). doi: 10.1128/JVI.00848-17. Print 2017 Aug 15.
4
Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1.
J Virol. 2002 Nov;76(22):11541-50. doi: 10.1128/jvi.76.22.11541-11550.2002.
5
PrP(c) expression influences the establishment of herpes simplex virus type 1 latency.
J Virol. 2002 Mar;76(5):2498-509. doi: 10.1128/jvi.76.5.2498-2509.2002.
6
Reduced herpes simplex virus type 1 latency in Flt-3 ligand-treated mice is associated with enhanced numbers of natural killer and dendritic cells.
Immunology. 2001 Mar;102(3):352-8. doi: 10.1046/j.1365-2567.2001.01180.x.
7
Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1.
Antimicrob Agents Chemother. 2001 Apr;45(4):1030-6. doi: 10.1128/AAC.45.4.1030-1036.2001.
8
Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study.
Antimicrob Agents Chemother. 1998 Jul;42(7):1555-62. doi: 10.1128/AAC.42.7.1555.
9
Comprehensive quantification of herpes simplex virus latency at the single-cell level.
J Virol. 1997 Jul;71(7):5423-31. doi: 10.1128/JVI.71.7.5423-5431.1997.
10
Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model.
Antimicrob Agents Chemother. 1996 Apr;40(4):846-51. doi: 10.1128/AAC.40.4.846.
本文引用的文献
1
A sensitive and precise plaque assay for herpes virus.
Nature. 1962 Sep 8;195:1028-9. doi: 10.1038/1951028a0.
2
MUTANT STRAINS OF HERPES SIMPLEX DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY.
Virology. 1964 Apr;22:493-502. doi: 10.1016/0042-6822(64)90070-4.
3
Interaction of herpes virus and HeLa cells: comparison of cell killing and infective center formation.
Virology. 1962 Jun;17:225-32. doi: 10.1016/0042-6822(62)90112-5.
4
Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds.
Antimicrob Agents Chemother. 1974 Mar;5(3):318-22. doi: 10.1128/AAC.5.3.318.
5
The pathogenesis of pseudorabies in mice following peripheral inoculation.
J Gen Virol. 1974 May;23(2):145-57. doi: 10.1099/0022-1317-23-2-145.
6
The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice.
J Hyg (Lond). 1978 Oct;81(2):267-77. doi: 10.1017/s0022172400025109.
7
9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.
Nature. 1978 Apr 13;272(5654):583-5. doi: 10.1038/272583a0.
8
Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.
Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716-20. doi: 10.1073/pnas.74.12.5716.
9
Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.
Infect Immun. 1977 Jun;16(3):842-8. doi: 10.1128/iai.16.3.842-848.1977.
10
Pathogenetic mechansims of recurrent herpes simplex virus infections.
Arch Virol. 1976;51(1-2):1-13. doi: 10.1007/BF01317829.
Zotero 插件